WALTHAM, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) -- BVI, a diversified global ophthalmic device company, today announced certification for its intraocular lens (IOL) portfolio under the European Medical Device Regulation (MDR, (EU) 2017/745) from its Notified Body, the British Standards Institution (BSI)¹. The new regulatory criteria came into effect in May 2021, replacing the prior Medical Device Directive (MDD). Leggi altro
Eventi
Vedi altri eventiNovità
BVI Announces ECAT Contract Additions for Government Customers
Government customers can now purchase BVI’s high-quality ophthalmic products through Lovell Government Services’ ECAT Contract. Leggi altro
BVI Announces Investment & Collaboration with Beyeonics Vision
Supports surgeon-centered digital visualization, improved ergonomics and real-timeguidance to surgical decision-making process Leggi altro
BVI Innovates to Treat Eye Diseases
BVI transformed from producing surgical knives to treating eye diseases as a next-generation company. Here’s how the business is still innovating. Leggi altro
BVI Launches new Hydrophobic PODEYE TORIC Intraocular Lens
BVI Launches New Hydrophobic PODEYE™ TORIC Intraocular Lens as Part of the PhysIOL Family of Lenses Leggi altro